Promising COVID treatment now available to residents at Gracedale, county officials say
Updated Feb 18, 2021;
Posted Feb 18, 2021
Virtua Health nurse Chioma Sullivan works in the monoclonal antibody infusion center Jan. 14, 2021, at Virtua Willingboro Hospital.Courtesy photo | For lehighvalleylive.com
Facebook Share
County Executive Lamont McClure and Gracedale Administrator Jennifer Stewart-King announced the new initiative Thursday.
Developed by Eli Lilly and Co., the treatment is called bamlanivimab and is being administered under an emergency use authorization issued last Nov. 9 by the U.S. Food and Drug Administration.
Gracedale staff will be working with St. Luke’s University Health Network and Advanced PICC Support to administer the treatment, according to a news release from the county.
New Apple Watch can help in early detection of heart failure
Researchers will compare data gathered by the Apple Watch and those regularly collected from various physical examinations that patients typically go through.
February 19, 2021 08:53 GMT
The University Health Network (UHN) in Canada announced the launch of the latest Apple Watch health study that will look into how the device can help in the early detection of heart failure. In a report filed by Newswise, the UHN research seeks to study how the Apple wearable can drive better clinical outcomes for heart failure patients.
A predator in waiting: Security researcher stumbles upon first Apple Silicon M1 malware
State officials realized last weekend that an unknown number of second doses of Moderna vaccine were administered as first doses, turning an already tumultuous vaccine rollout even further on its head.
Barry Ciccocioppo, COVID-19 press secretary for the Department of Health, said Thursday that communication from the department needs to be clearer regarding which vaccines are first doses and which are second doses, and said that pharmacies that misadministered doses shouldn t bear all the blame. We re not saying necessarily that it was the pharmacies who made a mistake, Ciccocioppo said. We re not trying to place blame on anyone.
Ciccocioppo said that the problem became evident when there was a much higher amount of second doses being requested from providers than what would be allocated by the federal government. The misadministration of doses has been happening over the past few weeks, he said